Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label wnt-3 A. Show all posts
Showing posts with label wnt-3 A. Show all posts

Wednesday, March 12, 2014

Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's disease

Sounds like a job for that great stroke association to follow up this research with stroke patients. No one else will do it.
http://www.sciencedirect.com/science/article/pii/S0166432813007717
Choose an option to locate/access this article:
Check if you have access through your login credentials or your institution
Check access

Highlights

3xTgAD mice show impaired danger assessment and reduced neurogenesis.
Overexpressing Wnt3a in the ventral hippocampus dentate gyrus improves their behavior.
The behavioral improvement is neurogenesis dependent.
Neurogenesis may be a therapeutic target for alleviating behavioral deficits in AD patients.

Abstract

Alzheimer's disease (AD) affects 13% of the population over the age of 65. Behavioral and neuropsychiatric symptoms are frequent and affect 80% of patients. Adult hippocampal neurogenesis, which is impaired in AD, is involved in learning and memory. It remains unclear, however, whether increasing adult neurogenesis improves behavioral symptoms in AD. We report that in the 3xTgAD mouse model of AD, chronic Wnt3a overexpression in the ventral hippocampus dentate gyrus (DG) restored adult neurogenesis to physiological levels. The restoration of adult neurogenesis led to full recovery of danger assessment impairment and the effect was blocked by ablation of neurogenesis with X-irradiation. Finally, using a bed nucleus of stria terminalis (BNST) mRNA expression array, we found that the expression of the 5-HT1A receptor in 3xTgAD mice is selectively decreased and normalized by Wnt3a overexpression in the ventral hippocampus DG, and this normalization is neurogenesis dependent. These findings indicate that reestablishing a functional population of hippocampal newborn neurons in adult AD mice rescues behavioral symptoms, suggesting that adult neurogenesis may be a promising therapeutic target for alleviating behavioral deficits in AD patients.

Tuesday, November 12, 2013

Making neurons from stem cells: Molecular mechanisms and spider silk substrates

Wouldn't you want spider silk as a substrate for new neural stem cells? A great thesis from Sweden.
A great stroke association would hire her immediately. Its only 62 pages long. 

Making neurons from stem cells: Molecular mechanisms and spider silk substrates

http://publications.ki.se/xmlui/bitstream/handle/10616/41804/Thesis_Michalina_Lewicka.pdf?sequence=3
ABSTRACT
The understanding of the function of the nervous system and the brain is one of the major intellectual challenges in life sciences. Neurological and psychiatric disorders are in addition major issues for the society, and new approaches are needed to learn more about the brain and to develop new treatments.
The development of the mammalian brain is a highly regulated process that involves extra- and intracellular signaling to efficiently regulate gene expression in a precise spatial and temporal manner.
The understanding of the differentiation mechanisms into neurons, glia and other cell types in the developing forebrain however is still incomplete. Studies of embryonic telencephalic neural stem cells (NSCs) in vitro may increase the understanding of the molecular mechanisms of brain development, and aid in developing new protocols for defined differentiation of stem cells for clinical use.
This thesis is aimed at investigating the mechanisms underlying bone morphogenetic protein (BMP4)-mediated differentiation of NSCs, and to explore the use of recombinant spider silk protein-based
matrices in combination with signaling factors, especially BMP4, to generate functional neural cell circuits in vitro.
In the first study, we discovered that BMP4 treatment of NSCs resulted in a dramatic increase in the expression of the BMP4-inhibitor Noggin. BMP4 mediated non-neural differentiation into mesenchymal cells at low seeding densities, neuronal differentiation at high seeding densities, and
astrocyte differentiation in any condition. As the Noggin levels increased linearly at higher densities, we hypothesized that the endogenous Noggin production predominantly mediated an inhibition of mesenchymal differentiation. We further observed that BMP4 stimulation induced an AMPA responsive neuron population at high seeding densities, and that this population was increased by costimulation of the signaling factor Wnt3a. By applying whole transcriptome sequencing, we aimed at elucidating the molecular mechanisms responsible for the increased neuronal differentiation by BMP4+Wnt3a. This approach, however, revealed an unexpected increase in the expression of genes associated with inhibitory GABAergic neurons, and also functional GABA-responsive neurons in the
culture. RNA knockdown experiments demonstrated that this GABAergic component was dependent on the expression of the neurogenic bHLH factor Hes6.
To apply these novel protocols for differentiation of NSCs into functional neurons, we introduced a novel way of culturing NSCs on substrates generated from recombinant spider silk protein (4RepCT).
Spider silk protein is a promising biomaterial due to its biocompatibility, biodegradability, and possibility to use in various forms both in 2D and 3D. NSCs cultured in 2D cultures on 4RepCT “film” structures showed no significant differences in cell proliferation, viability, or differentiation potential compared to control cultures in optimized conditions. 4RepCT substrates generated as “foam” structures could be used for 3D culturing of NSCs, and these NSC cultures differentiated nicely into astrocytes and neurons. Calcium imaging assays revealed that BMP4+Wnt3a-treatment of NSCs grown in 3D 4RepCT-matrices resulted in efficient generation of functional excitatory neurons.
These studies have thus revealed new molecular mechanisms underlying neural differentiation of cortical stem cells, and point to the versatility of using spider silk protein-based substrates for stem cell cultures. Future studies aim at testing these new concepts in vivo for improved treatment of neurological disease.

Thursday, March 28, 2013

Up-regulation of the canonical Wnt-3 A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia

More hedgehogs, get your researcher involved.
http://www.sciencedirect.com/science/article/pii/S0014299913002203

Abstract

In experimental cerebral ischemia, melanocortin MC4 receptor agonists induce neuroprotection and neurogenesis with subsequent long-lasting functional recovery. Here we investigated the molecular mechanisms underlying melanocortin-induced neurogenesis. Gerbils were subjected to transient global cerebral ischemia, then they were treated every 12 h, and until sacrifice, with 5-bromo-2’-deoxyuridine (BrdU; to label proliferating cells), and the melanocortin analog [Nle4,D-Phe7]α-melanocyte-stimulating hormone (NDP-α-MSH) or saline. NDP-α-MSH increased hippocampus dentate gyrus (DG) expression of Wnt-3 A, β-catenin, Sonic hedgehog (Shh), Zif268, interleukin-10 (IL-10) and doublecortin (DCX), as detected at days 3, 6 and 10 after the ischemic insult. Further, an elevated number of BrdU immunoreactive cells was found at days 3 and 10, and an improved histological picture with reduced neuronal loss at day 10, associated with learning and memory recovery. Pharmacological blockade of the Wnt-3 A/β-catenin and Shh pathways, as well as of melanocortin MC4 receptors, prevented all effects of NDP-α-MSH. These data indicate that, in experimental brain ischemia, treatment with melanocortins acting at MC4 receptors induces neural stem/progenitor cell proliferation in the DG by promptly and effectively triggering the canonical Wnt-3 A/β-catenin and Shh signaling pathways. Activation of these pathways is associated with up-regulation of the repair factor Zif268 and the neurogenesis facilitating factor IL-10, and it seems to address mainly towards a neuronal fate, as indicated by the increase in DCX positive cells.